These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38566882)

  • 21. Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti-muscle specific kinase antibodies.
    Beland B; Hahn C; Jamani K; Chhibber S; White C; Atkins H; Storek J
    Muscle Nerve; 2023 Feb; 67(2):154-157. PubMed ID: 36527328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.
    Wolfe GI; Oh SJ
    Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review.
    Pugliese A; Nicocia G; Messina S; Toscano A; Rodolico C
    Neuromuscul Disord; 2023 Feb; 33(2):145-147. PubMed ID: 36628839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The high frequency and clinical feature of seronegative myasthenia gravis in Southern China.
    Feng HY; Wang HY; Liu WB; He XT; Huang X; Luo CM; Li Y
    Neurol Sci; 2013 Jun; 34(6):919-24. PubMed ID: 22829131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients.
    Wang L; Wang S; Yang H; Han J; Zhao X; Han S; Zhang Y; Lv J; Zhang J; Li M; Ji Y; Zhou S; He X; Fang H; Yang J; Zhang Y; Zhang Q; Gao P; Gao F
    Brain Behav; 2021 Jul; 11(7):e02203. PubMed ID: 34075720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse?
    Triplett JD; Hardy TA; Riminton DS; Chu SYK; Reddel SW
    Muscle Nerve; 2019 Sep; 60(3):307-311. PubMed ID: 31177576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis.
    Kim SW; Sunwoo MK; Kim SM; Shin HY; Sunwoo IN
    J Clin Neurol; 2017 Jul; 13(3):287-292. PubMed ID: 28516744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.
    Yang L; Maxwell S; Leite MI; Waters P; Clover L; Fan X; Zhang D; Yang C; Beeson D; Vincent A
    J Neurol Sci; 2011 Feb; 301(1-2):71-6. PubMed ID: 21131008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma Myokine Profiles in Patients With AChR- and MuSK-Ab-Positive Myasthenia Gravis.
    Seok JW; Lee J; Kim M; Kim MJ; Shin HY; Kim SW
    J Clin Neurol; 2023 Sep; 19(5):469-477. PubMed ID: 37455510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
    PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG; Sidnev DV; Karganov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymolipoma-associated Myasthenia Gravis with High Titer of Anti-MuSKAb: A Case Report.
    Poursadeghfard M; Abolhasani Foroughi A; Karamimagham S
    Int J Mol Cell Med; 2019; 8(1):90-93. PubMed ID: 32195208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
    Leite MI; Jacob S; Viegas S; Cossins J; Clover L; Morgan BP; Beeson D; Willcox N; Vincent A
    Brain; 2008 Jul; 131(Pt 7):1940-52. PubMed ID: 18515870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis.
    Spagni G; Gastaldi M; Businaro P; Chemkhi Z; Carrozza C; Mascagna G; Falso S; Scaranzin S; Franciotta D; Evoli A; Damato V
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36270951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study of the safety and efficacy of rituximab in Iranian patients with myasthenia gravis: A single-center experience.
    Ziaadini B; Karimi N; Panahi A; Okhovat AA; Fatehi F; Nafissi S
    Curr J Neurol; 2022 Apr; 21(2):91-97. PubMed ID: 38011443
    [No Abstract]   [Full Text] [Related]  

  • 36. [Correlation between clinical manifestation, prognosis and antibody in anti-muscle-specific tyrosine kinase antibody positive myasthenia gravis].
    Tan Y; Zhu L; Huang YY; Shi JY; Li J; Li K; Guan YZ; Cui LY
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(31):2433-2437. PubMed ID: 34399555
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
    Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
    JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
    Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J
    Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to treatment of myasthenia gravis according to clinical subtype.
    Akaishi T; Suzuki Y; Imai T; Tsuda E; Minami N; Nagane Y; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Murai H; Aoki M; Utsugisawa K
    BMC Neurol; 2016 Nov; 16(1):225. PubMed ID: 27855632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myasthenia gravis with muscle-specific tyrosine kinase antibodies: A narrative review.
    Morren J; Li Y
    Muscle Nerve; 2018 Sep; 58(3):344-358. PubMed ID: 29461627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.